INSIGHTS ON CLINICAL TRIAL PARTNERING

• Building One Home for Sites

  Watch this presentation and demonstration of One Home for Sites for the latest updates on how the industry is coming together — even competitors — to alleviate the technology burden on research sites.

• 8 Critical Questions To Ask Your IRB

  This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.

• The Vision That's Reimagining Clinical Development

  Learn how Medable is working to turn fragmented, sequential processes into continuous progress, accelerating the path from protocol to patient for our clients.

• Expedite Drug Development With An Integrated CDMO-CRO Model

  From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.

• Breaking Free From Process Paralysis In Clinical Trials

  1/13/2025

  Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.

• Meeting Eye Exam Needs At The Point Of Need

  3/11/2025

  Learn more about how mobile vision clinics supported the staff at trial sites as well as the patients through the COVID-19 pandemic and beyond.

• Why ddPCR Is Becoming The Standard For Gene Therapy Biodistribution

  3/9/2026

  ddPCR is becoming essential for biodistribution because it delivers precise, low‑copy quantification qPCR can’t reliably match. Sponsors need partners with true ddPCR depth to ensure consistent, defensible data across tissues and studies.

• Stipends Create More Tax Burden — Here's A Better Option

  7/22/2025

  Explore the tax reporting requirements, including the threshold for payments requiring a 1099 form rising from $600 to $2,000 in 2026.

• GLP Compliance In A Modern Lab: What Compliant Actually Requires In 2025

  3/9/2026

  GLP compliance isn’t binary. Real defensibility depends on rigorous QA, validated electronic systems, and operational maturity — not just a label.